These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 10692608

  • 1. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.
    Porta M.
    Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608
    [Abstract] [Full Text] [Related]

  • 2. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache.
    Porta M.
    Curr Rev Pain; 2000 Mar; 4(1):31-5. PubMed ID: 10998713
    [Abstract] [Full Text] [Related]

  • 3. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.
    Kamanli A, Kaya A, Ardicoglu O, Ozgocmen S, Zengin FO, Bayik Y.
    Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199
    [Abstract] [Full Text] [Related]

  • 4. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
    Lang AM.
    Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
    [Abstract] [Full Text] [Related]

  • 5. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
    Seo HG, Bang MS, Chung SG, Jung SH, Lee SU.
    Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans.
    De Andrés J, Adsuara VM, Palmisani S, Villanueva V, López-Alarcón MD.
    Reg Anesth Pain Med; 2010 Mar; 35(3):255-60. PubMed ID: 20921836
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
    Jadhao VA, Lokhande N, Habbu SG, Sewane S, Dongare S, Goyal N.
    Indian J Dent Res; 2017 Mar; 28(5):493-497. PubMed ID: 29072209
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series.
    Baker JS, Nolan PJ.
    J Am Dent Assoc; 2017 Jan; 148(1):33-39. PubMed ID: 28314397
    [Abstract] [Full Text] [Related]

  • 9. An update on botulinum toxin A injections of trigger points for myofascial pain.
    Zhou JY, Wang D.
    Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type A and myofascial pain syndrome: a retrospective study of 301 patients.
    Avendaño-Coy J, Gómez-Soriano J, Valencia M, Estrada J, Leal F, Ruiz-Campa R.
    J Back Musculoskelet Rehabil; 2014 Jan; 27(4):485-92. PubMed ID: 24867895
    [Abstract] [Full Text] [Related]

  • 11. Use of botulinum toxin in the treatment of chronic myofascial pain.
    De Andrés J, Cerda-Olmedo G, Valía JC, Monsalve V, Lopez-Alarcón, Minguez A.
    Clin J Pain; 2003 Jan; 19(4):269-75. PubMed ID: 12840622
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
    Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG.
    Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
    [Abstract] [Full Text] [Related]

  • 13. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome.
    Gottsch HP, Yang CC, Berger RE.
    Scand J Urol Nephrol; 2011 Feb; 45(1):72-6. PubMed ID: 21062115
    [Abstract] [Full Text] [Related]

  • 14. A critical appraisal of the evidence for botulinum toxin type A in the treatment for cervico-thoracic myofascial pain syndrome.
    Desai MJ, Shkolnikova T, Nava A, Inwald D.
    Pain Pract; 2014 Feb; 14(2):185-95. PubMed ID: 23692187
    [Abstract] [Full Text] [Related]

  • 15. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A, Andriolo RB, Atallah AN, da Silva EM.
    Cochrane Database Syst Rev; 2012 Apr 18; (4):CD007533. PubMed ID: 22513950
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of myofascial pain syndrome (MPS) with botulinum toxin type A (BoNT-A)].
    Günther O, Bitterlich N.
    MMW Fortschr Med; 2011 Jul 21; 153 Suppl 2():64-9. PubMed ID: 23964470
    [Abstract] [Full Text] [Related]

  • 17. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
    Ojala T, Arokoski JP, Partanen J.
    Clin J Pain; 2006 Jan 21; 22(1):90-6. PubMed ID: 16340597
    [Abstract] [Full Text] [Related]

  • 18. Safety and Efficacy of PrabotulinumtoxinA (Nabota®) Injection for Cervical and Shoulder Girdle Myofascial Pain Syndrome: A Pilot Study.
    Kim DY, Kim JM.
    Toxins (Basel); 2018 Sep 03; 10(9):. PubMed ID: 30177597
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A, Andriolo RB, Atallah AN, da Silva EM.
    Cochrane Database Syst Rev; 2014 Jul 25; 2014(7):CD007533. PubMed ID: 25062018
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
    Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G.
    Cranio; 2008 Apr 25; 26(2):126-35. PubMed ID: 18468272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.